Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck, Sanofi’s Gardasil Beats Glaxo’s Rival Vaccine on Cost
Bloomberg
Tuesday, September 27, 2011 - 7:32pm
tags:
HPV, Gardasil, vaccines, Sanofi, GSK, Cervarix
Bristol-Myers Squibb Zeroes In On A Blockbuster Cancer Drug
Seeking Alpha
Tuesday, September 27, 2011 - 7:31pm
tags:
Bristol-Myers Squibb, Orencia, MDX-1106, BMS-936558, Ono Pharmaceutical
J&J's Doxil Woes Show Shortages Aren't Easily Fixed
Motley Fool
Tuesday, September 27, 2011 - 7:26pm
tags:
Doxil, JNJ, drug shortages, cancer
No consolation for Sanofi as Genzyme scrambles
Fierce Pharma
Tuesday, September 27, 2011 - 12:02pm
tags:
Genzyme, Sanofi
Tianyin Pharmaceuticals' Management Discusses Q4 2011 Results - Earnings Call Transcript
Seeking Alpha
Tuesday, September 27, 2011 - 12:00pm
tags:
earnings, Tianyin Pharmaceutical
Will the FDA Yank Bayer’s Risky Birth-Control Pill Yaz?
BNET Pharma
Tuesday, September 27, 2011 - 11:59am
tags:
Bayer, birth control pill, FDA, Yaz, Yasmin
Pens Vs. Payments In Pharmaceutical Marketing
Forbes
Tuesday, September 27, 2011 - 11:53am
tags:
physician payments
Why Pharma Stocks Can Rise Before Trial Results
Pharmalot
Tuesday, September 27, 2011 - 11:39am
tags:
clinical trials, drug stocks
Are You Watching This Trend at Illumina?
Motley Fool
Tuesday, September 27, 2011 - 11:38am
tags:
Illumina, Complete Genomics, Qiagen, Life Technologies
When 'Accelerated' FDA Reviews Are Slow
TheStreet.com
Tuesday, September 27, 2011 - 11:26am
tags:
FDA, Marqibo, leukemia, Talon Therapeutics
ImmunoGen CEO on New Breast Cancer Drug
CNBC
Tuesday, September 27, 2011 - 11:23am
tags:
breast cancer, Immunogen, T-DM1
Is GlaxoSmithKline Working Hard Enough for You?
Motley Fool
Tuesday, September 27, 2011 - 11:21am
tags:
GSK
Gates-Backed Fund to Buy $1 Billion of Glaxo, Pfizer Shots
Bloomberg
Tuesday, September 27, 2011 - 11:21am
tags:
Bill Gates, GSK, Pfizer, philanthropy
Novartis Says Drug Improves COPD Symptoms
FOX Business
Tuesday, September 27, 2011 - 11:19am
tags:
COPD, Novartis, NVA237
FDA Panel, Bayer Birth Control Pills & Blood Clots
Pharmalot
Monday, September 26, 2011 - 10:30pm
tags:
advisory panels, blood clots, birth control pill, FDA, Bayer, Yasmin, Yaz
Alexion, Celgene Resilient Vs. Volatile Market
Investors.com
Monday, September 26, 2011 - 10:29pm
tags:
Celgene, Alexion, Soliris, Revlimid
Statins for Primary Prevention: the Debate Continues
Forbes
Monday, September 26, 2011 - 10:27pm
tags:
statins
How Eli Lilly Will Outwit Patent Expirations
Seeking Alpha
Monday, September 26, 2011 - 10:26pm
tags:
patents, Eli Lilly
Medicis Settles Case Alleging CEO Shacknai Cooked the Books
BNET Pharma
Monday, September 26, 2011 - 12:23pm
tags:
Medicis, Jonah Shacknai
2 Positive Signs for Ariad Pharmaceuticals
Motley Fool
Monday, September 26, 2011 - 12:21pm
tags:
Ariad Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.